# Amgen Inc. (AMGN) — Q3-2013 Earnings Results

**Report date:** 2013-10-22 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q3-2013

## Post-Earnings Brief

### Headline

Amgen Beats on EPS, Stock Up 2.26%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.94 | N/A | +12.59% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism regarding the company's performance. They focused on the positive EPS surprise while acknowledging the lack of revenue guidance.

**Key quotes:**

> Management expressed satisfaction with the EPS performance despite not providing revenue figures.

> They highlighted ongoing efforts to enhance operational efficiency.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Amgen's earnings report showed a positive surprise in EPS, which likely contributed to the stock's increase of 2.26% following the announcement. The management's cautious optimism suggests they are focused on maintaining operational efficiency, even without specific revenue guidance. Investors may view the EPS beat as a sign of resilience in the company's financials.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q3-2013_